Streetbeat News

Stock Prices

RNLX

Renalytix plc (NASDAQ:RNLX) announced the U.S. Government's approval to add its kidneyintelX.dkd test to a 10-year Governmentwide Acquisition Contract for early-stage kidney disease testing, effective March 1, 2024. The test is priced at $950 per result. This contract allows for testing services at any government healthcare facility, including the U.S. Veterans Administration and Department of Defense. Additionally, Medicare's consideration of a coverage policy for KidneyIntelX could lead to insurance reimbursement for millions of patients. RNLX shares surged 32.50% to $1.10.

Portfolio Pulse from Vandana Singh

February 29, 2024 | 5:51 pm

RXST

Stifel analyst Thomas Stephan has maintained a Buy rating on RxSight (NASDAQ:RXST) and increased the price target from $54 to $64. This adjustment reflects a positive outlook on RxSight's stock performance.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 5:46 pm

ROKU

Financial analysis reveals a bearish sentiment among traders on Roku (NASDAQ:ROKU), with 59% showing bearish tendencies in recent options activity. The analysis highlighted 27 unusual trades, with a significant portion being calls. The price window eyed by traders ranges from $20.0 to $110.0. Roku, a leading streaming platform, is currently trading up by 1.74% at $64.82, with potential oversold conditions indicated by RSI readings. The company's earnings release is anticipated in 55 days.

Portfolio Pulse from Benzinga Insights

February 29, 2024 | 5:46 pm

MSFT

OKTA

Okta Inc (NASDAQ:OKTA) shares surged after reporting strong Q4 results, with several analysts raising their price targets. The company's performance was highlighted by robust growth and minimal impact from a recent security breach. Analysts remain optimistic about Okta's positioning in the identity management market despite increasing competition, particularly from Microsoft Corp (NASDAQ:MSFT).

Portfolio Pulse from Priya Nigam

February 29, 2024 | 5:45 pm

GSK

HLN

Haleon Plc (NYSE:HLN) reported a 4.1% Y/Y increase in FY 2023 revenues to £11.3 billion, missing consensus estimates. Organic revenue grew by 8.0%, with adjusted operating profit up 10.4% in constant currency. The company announced a £500 million share buyback for 2024 and expects organic revenue growth of 4%-6% for the year. Disposals of Lamisil and ChapStick are expected to dilute FY 2024 revenue and profit by 1% and 3%, respectively. HLN shares rose 5.71% to $8.52.

Portfolio Pulse from Vandana Singh

February 29, 2024 | 5:45 pm

AAPL

GOOG

RIVN

TSLA

Apple Inc's abandoned electric vehicle (EV) project, known as Titan, considered using Siri as a steering mechanism and had explored a deal with Tesla Inc. The project, which began in 2014, faced multiple stalls and leadership changes. Apple's initial vision included a car without a steering wheel, controlled by Siri, resembling a European minivan. The development of Apple's EV followed failed acquisition talks with Tesla, where Elon Musk sought to be CEO of the combined entity, leading to the collapse of negotiations. Apple's interest in the EV market remains, with speculation about potential acquisitions like Rivian Automotive.

Portfolio Pulse from Chris Katje

February 29, 2024 | 5:43 pm

MBI

MRAI

ROOT

SLQT

Insurance stocks experienced notable movements in Thursday's intraday session. Gainers included Root, SelectQuote, Conifer Holdings, Lemonade, Fanhua, and Maiden Holdings, with increases ranging from 3.77% to 16.33%. Losers were Marpai, MBIA, Huize Holding, Assured Guaranty, Ambac Financial Group, and Intl General Insurance, with declines between 2.64% and 5.41%. Notably, Lemonade, MBIA, Assured Guaranty, and Ambac Financial Group recently released their Q4 earnings.

Portfolio Pulse from Benzinga Insights

February 29, 2024 | 5:40 pm

VLCN

Volcon, Inc. (NASDAQ:VLCN) shares surged 36.36% to $1.65 after announcing the delivery of its first production vehicle, the Volcon Stag, to the U.S. Army Corps of Engineers for evaluation. This marks a significant rebound following a 100% dip over the last year. The company's CEO, John Kim, highlighted the successful launch of the Stag, the fastest-production electric UTV, and the ongoing full production of Grunt EVO motorcycles. Volcon aims to ramp up Stag production and sales while continuing its electric motorcycle deliveries globally.

Portfolio Pulse from Nabaparna Bhattacharya

February 29, 2024 | 5:37 pm

ABNB

AMZN

BABA

CMG

LULU

PDD

RIVN

SBUX

TSLA

XPEV

Today's session highlighted significant whale activity in the options market for 10 consumer discretionary stocks, indicating potential trading opportunities. Notable bullish sentiment was observed in TSLA, AMZN, RIVN, XPEV, LULU, and BABA options, while ABNB and PDD showed bearish sentiment. SBUX and CMG options displayed neutral sentiment. The activity involved both call and put options across various expiration dates and strike prices, suggesting diverse strategies by large investors.

Portfolio Pulse from Benzinga Insights

February 29, 2024 | 5:35 pm

AKRO

ALNY

CVS

IOVA

LLY

MOH

NVAX

PRTA

VKTX

Today's session highlighted significant whale activity in the health care sector, focusing on options trading for stocks like NVAX, CVS, IOVA, VKTX, MOH, LLY, ALNY, AKRO, CI, and PRTA. The trades varied in sentiment from bearish to bullish, with notable investments in both put and call options across various expiration dates and strike prices. This activity could indicate market movements or investor expectations for these companies.

Portfolio Pulse from Benzinga Insights

February 29, 2024 | 5:35 pm